nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)
|
Usonis, V. |
|
2003 |
21 |
31 |
p. 4588-4592 5 p. |
artikel |
2 |
A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season
|
Kawai, Naoki |
|
2003 |
21 |
31 |
p. 4507-4513 7 p. |
artikel |
3 |
Bacterial otitis media: a new non-invasive rat model
|
Tonnaer, Edith L.G.M |
|
2003 |
21 |
31 |
p. 4539-4544 6 p. |
artikel |
4 |
Development of a rapid method for determining the infectious dose (ID)50 of Orientia tsutsugamushi in a scrub typhus mouse model for the evaluation of vaccine candidates
|
Chan, T.C |
|
2003 |
21 |
31 |
p. 4550-4554 5 p. |
artikel |
5 |
Development of a vaccine for immunization against classical as well as variant strains of infectious bursal disease virus using reverse genetics
|
Mundt, Egbert |
|
2003 |
21 |
31 |
p. 4616-4624 9 p. |
artikel |
6 |
DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice
|
Kamachi, Kazunari |
|
2003 |
21 |
31 |
p. 4609-4615 7 p. |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
2003 |
21 |
31 |
p. IFC- 1 p. |
artikel |
8 |
Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection
|
Sasaki, Maria das Graças |
|
2003 |
21 |
31 |
p. 4545-4549 5 p. |
artikel |
9 |
Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime–adenovirus boost
|
Park, Su-Hyung |
|
2003 |
21 |
31 |
p. 4555-4564 10 p. |
artikel |
10 |
Hepatitis A vaccine failure: how to treat the threat
|
Taliani, Gloria |
|
2003 |
21 |
31 |
p. 4505-4506 2 p. |
artikel |
11 |
Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination
|
Rottinghaus, Scott T |
|
2003 |
21 |
31 |
p. 4604-4608 5 p. |
artikel |
12 |
Mass psychogenic illness following oral cholera immunization in Ca Mau City, Vietnam
|
Khiem, Ha Ba |
|
2003 |
21 |
31 |
p. 4527-4531 5 p. |
artikel |
13 |
Modelling measles re-emergence as a result of waning of immunity in vaccinated populations
|
Mossong, Joël |
|
2003 |
21 |
31 |
p. 4597-4603 7 p. |
artikel |
14 |
Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine
|
Kuzuhara, Syoji |
|
2003 |
21 |
31 |
p. 4519-4526 8 p. |
artikel |
15 |
Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice
|
Takasaki, Tomohiko |
|
2003 |
21 |
31 |
p. 4514-4518 5 p. |
artikel |
16 |
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects
|
Cross, Alan S |
|
2003 |
21 |
31 |
p. 4576-4587 12 p. |
artikel |
17 |
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin
|
Watanabe, Izumi |
|
2003 |
21 |
31 |
p. 4532-4538 7 p. |
artikel |
18 |
Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins
|
Blanchard, P |
|
2003 |
21 |
31 |
p. 4565-4575 11 p. |
artikel |
19 |
Rabies DNA vaccine in the horse: strategies to improve serological responses
|
Fischer, Laurent |
|
2003 |
21 |
31 |
p. 4593-4596 4 p. |
artikel |